• By ICR Secretariat
  • Posted Sunday, June 9, 2019

ASCO: In early study results, Grail's blood test identifies 12 cancers before they spread

https://www.fiercebiotech.com/medtech/asco-grail-s-blood-test-identifies-a-dozen-cancers-before-they-can-spread-early-results

New, early data from Grail showed its liquid biopsy test not only was able to detect the presence of 12 different kinds of early-stage cancer but could also identify the disease’s location within the body before it spreads using signatures found in the bloodstream.